Description
Description
Retatrutide (20mg) is a triple agonist targeting GIP, GLP-1, and glucagon receptors. This concentration is used in metabolic research to study the physiological effects of multi-pathway activation.
Research Applications
Research focuses on energy homeostasis and the synergistic effects of triple receptor modulation.
Reviews
There are no reviews yet.